0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
100.00%
Revenue growth of 100.00% while ECL.AX is flat. Bruce Berkowitz would check if a small edge can widen further.
-39.64%
Negative gross profit growth while ECL.AX is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
50.46%
EBIT growth of 50.46% while ECL.AX is zero. Bruce Berkowitz would see if small gains can be scaled further.
50.46%
Operating income growth of 50.46% while ECL.AX is zero. Bruce Berkowitz would see if this modest edge can become significant.
100.00%
Net income growth of 100.00% while ECL.AX is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
133.33%
EPS growth of 133.33% while ECL.AX is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
75.00%
Diluted EPS growth of 75.00% while ECL.AX is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
-4.47%
Share reduction while ECL.AX is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
3.45%
Diluted share change of 3.45% while ECL.AX is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
100.00%
OCF growth of 100.00% while ECL.AX is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
100.00%
FCF growth of 100.00% while ECL.AX is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
No Data
No Data available this quarter, please select a different quarter.
414.58%
5Y revenue/share CAGR above 1.5x ECL.AX's 61.63%. David Dodd would look for consistent product or market expansions fueling outperformance.
445.84%
3Y revenue/share CAGR above 1.5x ECL.AX's 44.25%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
474.69%
5Y OCF/share CAGR above 1.5x ECL.AX's 13.67%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
639.05%
3Y OCF/share CAGR above 1.5x ECL.AX's 148.13%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
No Data
No Data available this quarter, please select a different quarter.
368.38%
Positive 5Y CAGR while ECL.AX is negative. John Neff might view this as a strong mid-term relative advantage.
117.46%
3Y net income/share CAGR above 1.5x ECL.AX's 56.68%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
758.22%
Positive 5Y equity/share CAGR while ECL.AX is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
113.64%
3Y equity/share CAGR above 1.5x ECL.AX's 16.09%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
204.81%
AR growth of 204.81% while ECL.AX is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.68%
BV/share growth of 4.68% while ECL.AX is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
6.55%
Debt shrinking faster vs. ECL.AX's 202.77%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.